Investment Highlights Proven Technologies Used in over 150,000 patients worldwide, with proven safety and effectiveness supported by clinical studies. Full in-house capabilities Full control across R&D, manufacturing, and commercialization, enabling efficient development, high quality, and faster market access. Core Technologies Driving Better Care We advance patient care through Degradable Starch Microspheres (DSM), Amniotic-Based Stem Cells, … Continue reading Reasons to invest